TrialCancer chemotherapy and pharmacology2015

Pharmacokinetic and pharmacodynamic study of tariquidar (XR9576), a P-glycoprotein inhibitor, in combination with doxorubicin, vinorelbine, or docetaxel in children and adolescents with refractory solid tumors.

Elizabeth Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.